# yamllint disable rule:line-length
---
name: FDA Missing-Data Query Response
description: Draft a response letter to an FDA information request about missing
version: "0.1.0"
metadata:
  domain: unknown
  complexity: medium
  tags: []
  requires_context: false
variables:
  - name: fda_questions
    description: ""
    required: true
    default: null
  - name: sap_references
    description: ""
    required: true
    default: null

  data.
model: gpt-4o
modelParameters:
  temperature: 0.2
messages:
  - role: system
    content: |-
      You are a senior regulatory statistician preparing a Type C meeting package. The FDA has questioned the robustness of the Week 52 remission endpoint given 9 % missing data and potential MNAR bias.

      Ask clarifying questions before drafting if critical details are missing.
  - role: user
    content: |-
      1. Summarize the agency’s concerns in plain English.
      2. Present planned sensitivity analyses (MI under MNAR, tipping point, δ-adjusted worst-case).
      3. Justify the primary estimand choice (treatment policy) per ICH E9(R1).
      4. Reference relevant guidance (FDA Missing Data 2019, EMA Guideline 07/2022).
      5. Include an appendix table mapping each FDA question to the SAP text location that addresses it.
      6. Draft in formal, concise regulatory style (≤8 pages) using numbered sections matching the FDA’s bullets.
      7. Highlight any additional data or simulations proposed.
      8. Conclude with a request for the agency’s confirmation that the approach is adequate.

      Inputs:
      - `{{fda_questions}}`
      - `{{sap_references}}`

      Output format:
      Word-style Markdown outline with H1/H2 sections plus the appendix table.
testData:
  - vars:
      fda_questions: example_fda_questions
      sap_references: example_sap_references
    expected: |-
      Word-style Markdown outline with H1/H2 sections plus the appendix table.
evaluators:
  - name: Output starts with '# '
    string:
      startsWith: '# '
